HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Certain Dri Antiperspirant Study Supports 48-Hour Claims – Numark

This article was originally published in The Rose Sheet

Executive Summary

Clinical testing by Numark Laboratories supports an "extra effective" enhanced duration claim for Certain Dri antiperspirant, according to the company

You may also be interested in...



OTC Antiperspirant Duration Claim Restrictions Contested By CTFA

Restricting enhanced duration claims under the OTC Antiperspirant Drug Products Final Monograph violates First Amendment principles and is inconsistent with FDA regulatory precedent, according to the Cosmetic, Toiletry and Fragrance Association

FDA Antiperspirant Monograph Partial Stay Permits Enhanced Duration

Under a partial stay of the OTC Antiperspirant Monograph, products claiming enhanced duration up to 48 hours will be permitted on the market while FDA reviews new data, the agency says in an Oct. 15 Federal Register notice

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013215

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel